Empagliflozin in Heart Failure: Diuretic and Cardio-Renal Effects
#VisualAbstract by @drM_sudha and @docanjuyadav
#NephJC #Nephpearls
👉🏼 nejm.org/doi/pdf/10.105…
👉🏼 ahajournals.org/doi/pdf/10.116…
Class effects of SGLT2 inhibitors on #cardiorenal outcomes ca. 2019 from @BioMedCentral @McCulloughBHVH #Nephpearls #NephJC
👉🏼 cardiab.biomedcentral.com/articles/10.11…
Diabetes and Kidney Disease: SGLT2 Inhibitors by @ChristosArgyrop in the August 2019 issue of @KidneyNews #Nephpearls #NephJC
👉🏼 asn-online.org/publications/k…
Check out 👉🏼 SGLT2 Inhibitors and #cardiorenal outcomes, which was written by @brendonneuen @kidney_boy and myself‼️
📌 This was our choice for ⚡️Kidney Watch 2019⚡️ published in the February 2019 issue of @KidneyNews
#Nephpearls #NephJC
👉🏼 kidneynews.org/kidneynews/11_…
SGLT2 inhibitors: diuretic perspective ca. 2017 from @JAMA_current @JAMACardio #Nephpearls #NephJC
👉🏼 pubmed.ncbi.nlm.nih.gov/28636701/
SGLT2 mechanism in the proximal tubule ca. 2016 from @CircAHA
#Nephpearls #NephJC
👉🏼 ahajournals.org/doi/pdf/10.116…
SGLT2 Inhibitors: The “tubular” hypothesis ca. 2016 from @CircAHA
#Nephpearls #NephJC
👉🏼 ahajournals.org/doi/pdf/10.116…
Ongoing trials of SGLT2 Inhibitors of interest to the Nephrology Community ca. 2019
Table by @drlovygaur #Nephpearls #NephJC
Renoprotective effects of SGLT2 Inhibitors ca. 2018 from @Kidney_Int
#Nephpearls #NephJC
👉🏼 kidney-international.org/article/S0085-…
Empagliflozin in Heart Failure: Diuretic and #Cardiorenal Effects 🥊
#Nephpearls #NephJC
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.